Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,405 USD | -1,06 % | +1,81 % | -87,07 % |
17/04 | MARINUS PHARMACEUTICALS, INC. : Truist Securities mantiene una recomendación de compra. | ZM |
16/04 | MARINUS PHARMACEUTICALS, INC. : Pasa de una recomendación de Compra a Neutral por Baird | ZM |
Resumen de negocios
Número de empleados: 166
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Therapeutics for Rare Seizures
100,0
%
| 25 | 100,0 % | 31 | 100,0 % | +21,63 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 25 | 100,0 % | 31 | 100,0 % | +21,63 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/09/18 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 12/04/21 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 06/11/19 |
Chief Tech/Sci/R&D Officer | - | - | |
Sonya Weigle
IRO | Public Communications Contact | - | 01/09/21 |
Christy Shafer
PRN | Corporate Officer/Principal | 48 | 10/11/20 |
General Counsel | - | - | |
Thomas Lyons
PRN | Corporate Officer/Principal | - | 01/01/18 |
Alex Aimetti
PRN | Corporate Officer/Principal | - | - |
Martha Manning
LAW | General Counsel | 69 | 15/06/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 01/12/08 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/09/18 |
Elan Ezickson
BRD | Director/Board Member | 60 | 12/12/19 |
Seth Fischer
BRD | Director/Board Member | 68 | 06/09/16 |
Sara Nochur
BRD | Director/Board Member | 63 | 22/03/21 |
Sarah Noonberg
BRD | Director/Board Member | 56 | 16/05/23 |
Director/Board Member | 41 | 26/01/23 | |
Charles Austin
BRD | Director/Board Member | 68 | 29/07/20 |
Marvin Johnson
BRD | Director/Board Member | 61 | 18/04/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 54 938 349 | 54 400 357 ( 99,02 %) | 7 307 ( 0,0133 %) | 99,02 % |
Información de la empresa
Marinus Pharmaceuticals, Inc.
5 Radnor Corporate Center 100 Matsonford Road
19087-5279, Radnor
+484 801 4670
http://www.marinuspharma.comRevisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-87,07 % | 77,17 M | |
+25,83 % | 661 mil M | |
+27,00 % | 566 mil M | |
-6,76 % | 352 mil M | |
+20,34 % | 332 mil M | |
+3,00 % | 283 mil M | |
+13,09 % | 231 mil M | |
+5,46 % | 200 mil M | |
-9,61 % | 195 mil M | |
-6,26 % | 145 mil M |
- Bolsa de valores
- Acciones
- Acción MRNS
- Empresa Marinus Pharmaceuticals, Inc.